CLEC10A and neoplasm: Functionally, HML-2 proteins contribute to multiple cancer hallmarks, including tumor growth, metastasis, immune evasion, and tumor-promoting inflammation, making them attractive targets for personalized treatment of aggressive tumor subsets with high expression.